Subcutaneously changeable vascular access port

ChangeBridge: Patent Grants - Medical Devices (A61M)

Published March 31st, 2026

Detected March 31st, 2026

Summary

USPTO granted Patent US12589231B2 to Portal Access Inc. on March 31, 2026, for a subcutaneously changeable vascular access port technology. The patent covers 20 claims for a port that transitions from delivery to deployed configuration subcutaneously. Inventor is Michael Gabriel Tal.

View original document View source feed page

What changed

USPTO issued Patent US12589231B2 to Portal Access Inc. on March 31, 2026, granting exclusive rights to a vascular access port designed to change configuration subcutaneously after implantation. The patent includes 20 claims covering the port body mechanism and methods for deploying the device in a patient's body. Filing date was March 3, 2020, with application number 17435475.

Patent holders and licensees should review the claims to understand the scope of protected technology and assess whether their vascular access port designs may infringe. Medical device companies developing similar subcutaneous port technologies should consider design-around strategies or seek licensing agreements. The patent provides exclusivity through March 3, 2040, based on the 20-year term from filing.

Source document (simplified)

← USPTO Patent Grants

Subcutaneously changeable vascular access port

Grant US12589231B2 Kind: B2 Mar 31, 2026

Assignee

Portal Access Inc.

Inventors

Michael Gabriel Tal

Abstract

Disclosed is a vascular access port selectively changeable subcutaneously from delivery configuration to deployed configuration. The vascular access port includes a port body and a port body extension being partly or wholly disengaged in the delivery configuration, and fixedly connected to form a unified structure of the vascular access port, greater in volume than the port body, in the deployed configuration. Methods and kits for deploying the vascular access port in a body of a subject are also disclosed.